• Tiếng Việt
    • English
  • Antibiotic

    INDICATIONS:
    Treatment of infections caused by susceptible organisms in the following cases:

    Blood infections, post-subcutaneous infections, lymphadenitis, secondary infections in cases of injury, burns or incisions, perianal abscesses, osteomyelitis, arthritis, tonsillitis (including pressure tonsil carcinoma), pneumonia, lung abscess, thoracic pus, secondary infections in chronic lung damage, complications of cystitis, pyelonephritis, peritonitis, cholecystitis, cholangitis , hepatic abscess, intrauterine infection, adnexitis, uterine inflammation, purulent meningitis, endophthalmitis (including inflammation of the whole eye), otitis media, sinusitis, cellulitis , osteoarthritis.

    DOSAGE AND ADMINISTRATION:

    Adults:
    The recommended MEIUNEM 0.5g dose is 500 mg every 8 hours for skin and skin structure infections and 1 g every 8 hours for intestinal infections. MEIUNEM 0.5g should be administered by intravenous line for 15-30 minutes. A dose of 1 g slow intravenous injection (5-20 ml) may be used for approximately 3-5 minutes.

    Use in adults with renal insufficiency:
    The dose should be reduced in adults with creatinni clearance of 50 ml / min or less

    Using the drug in children:
    For children 3 months and older, the MEIUNEM 0.5g dose is 10.20 or 40mg / kg every 8 hours (the maximum dose is 2g every 8 hours), depending on the type of infection. Pediatric patients weighing more than 50 kg should use MEIUNEM 0.5g at a dose of 500mg every 8 hours in the abdomen and 2g every 8 hours for meningitis. MEIUNEM 0.5g should be administered by intravenous infusion for 15-30 minutes or slow intravenous injection (5-20ml) for approximately 3-5 minutes.

    Method of infusion:

    Normally, dissolve 0.5 g (active) meropenem in ≥ 100mL of isotonic sodium chloride (JP) solution. Do not mix with distilled water for injection because doing so, the solution after mixing will not be isotonic.

    CONTRAINDICATIONS:

    MEROPENEM is contraindicated for the following patients:
    Patients with a history of hypersensitivity to any ingredient of the drug.
    The patient is being treated with sodium valproate.

    STORAGE:

    Store at temperatures below 30oC

    STANDARD: JP XVI

    SHELF LIFE:
    36 months from date of manufacture

    MANUFACTURER:

    NIPRO PHARMA CORPORATION ODATE PLANT
    Address: 5-7, Maedano, Niida, Odate, Akita, Japan
    Tel: + 81-186-44-8650 / Fax: + 81-186-44-8690

    Comment